Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Urinary System Neoplasm	NCIT_C3431	[A benign or malignant, primary or metastatic neoplasm involving the urinary system.]
Extra-Adrenal Paraganglioma	NCIT_C3309	[A benign or malignant paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland.]
Group C/Treatment IND Protocol	NCIT_C15478	[A means for providing compassionate use of investigational agents between the time that an agent has been shown to have anti-tumor activity and the time that drug becomes available on the market. Investigational agents that have been given Group C/Treatment IND designation by the FDA have reproducible efficacy in one or more specific tumor types. Such an agent is likely to alter the pattern of treatment of the disease and can be safely administered by properly trained physicians without specialized supportive care facilities. If a drug meets these criteria CTEP may initiate a formal application to the FDA to authorize Group C distribution for a specific indication. Such approval is not equivalent to formal FDA approval of effectiveness for this indication. Any registered investigator may receive a Group C agent.]
Protocol	NCIT_C42651	[A rule which guides how an activity should be performed.]
Central Nervous System Neoplasms by Morphology	NCIT_C7040
Immune Globulin/Zidovudine	NCIT_C15479	[A combination of agents containing immune globulin and zidovudine.]
Therapeutic Immune Globulin	NCIT_C2701	[A preparation of plasma proteins derived from the pooled plasma of adult donors. Largely comprised of IgG antibodies, therapeutic immune globulin provides passive immunization by increasing the recipient's serum levels of circulating antibodies. IgG antibodies have multiple functions, including binding to and neutralizing bacterial toxins; opsonization of pathogens; activation of complement; and suppression of pathogenic cytokines and phagocytes through binding to CD5, interleukin-1a (IL-1a), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and T-cell receptors. Therapeutic immune globulin may diminish pathogenic mechanisms in some autoimmune diseases by binding to and inhibiting the activity of autoantibodies. (NCI04)]
Colon Tubular Adenoma	NCIT_C7041	[A usually polypoid neoplasm that arises from the glandular epithelium of the colonic mucosa. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features.]
Colorectal Tubular Adenoma	NCIT_C27456	[A usually polypoid neoplasm that arises from the glandular epithelium of the colonic and rectal mucosa. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features.]
Colon Adenoma	NCIT_C3864	[An adenoma that arises from the colon. The group of colonic adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis.]
Colon Ganglioneuroma	NCIT_C7042	[A ganglioneuroma that arises from the colon. It usually presents as a small mucosal polyp.]
Colorectal Ganglioneuroma	NCIT_C96514	[A ganglioneuroma that arises from the colon or rectum. It usually presents as a small mucosal polyp.]
Benign Colon Neoplasm	NCIT_C2894	[A non-metastasizing neoplasm arising from the wall of the colon.]
Grade 4 Venous Injury, CTCAE	NCIT_C146190	[Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated]
Venous Injury, CTCAE	NCIT_C143933	[A finding of damage to a vein.]
Grade 4 Ventricular Arrhythmia, CTCAE	NCIT_C146191	[Life-threatening consequences; hemodynamic compromise]
Ventricular Arrhythmia, CTCAE 5.0	NCIT_C146629	[A disorder characterized by a dysrhythmia that originates in the ventricles.]
Grade 4 Visceral Arterial Ischemia, CTCAE	NCIT_C146192	[Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated]
Visceral Arterial Ischemia, CTCAE	NCIT_C143938	[A disorder characterized by a decrease in blood supply due to narrowing or blockage of a visceral (mesenteric) artery.]
Grade 4 Vision Decreased, CTCAE	NCIT_C146193	[Best corrected visual acuity of 20/200 or worse in the affected eye]